Pictet Asset Management Portfolio holdings
AUM
$98.3B
1-Year Return
21%
This Quarter Return
+15.36%
1 Year Return
+21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$90.7B
AUM Growth
+$9.6B
(+12%)
Cap. Flow
-$1.35B
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
15.6%
Holding
2,046
New
101
Increased
729
Reduced
551
Closed
85
Top Buys
| 1 |
Veralto
VLTO
|
$329M |
| 2 |
Broadcom
AVGO
|
$225M |
| 3 |
Zscaler
ZS
|
$203M |
| 4 |
NVIDIA
NVDA
|
$159M |
| 5 |
Stantec
STN
|
$156M |
Top Sells
| 1 |
SPLK
Splunk Inc
SPLK
|
$906M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$209M |
| 3 |
Johnson Controls International
JCI
|
$155M |
| 4 |
WRK
WestRock Company
WRK
|
$126M |
| 5 |
Adobe
ADBE
|
$120M |
Sector Composition
| 1 | Technology | 30.13% |
| 2 | Industrials | 16.85% |
| 3 | Healthcare | 15.4% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Utilities | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Johnson & Johnson
JNJ
$431B
| $196M | 0.22% |
1,249,470
-15,545
| -1% | -$2.44M |
|
127
Starbucks
SBUX
$98.9B
| $195M | 0.21% |
2,029,124
+63,059
| +3% | +$6.05M |
|
128
Prologis
PLD
$105B
| $188M | 0.21% |
1,410,574
-3,703
| -0.3% | -$494K |
|
129
Procter & Gamble
PG
$373B
| $186M | 0.21% |
1,272,235
-114,149
| -8% | -$16.7M |
|
130
Accenture
ACN
$158B
| $180M | 0.2% |
511,830
+8,613
| +2% | +$3.02M |
|
131
RingCentral
RNG
$2.76B
| $179M | 0.2% |
5,277,090
-241,797
| -4% | -$8.21M |
|
132
Moderna
MRNA
$9.45B
| $179M | 0.2% |
1,797,450
+407,441
| +29% | +$40.5M |
|
133
Ionis Pharmaceuticals
IONS
$9.46B
| $178M | 0.2% |
3,518,317
+277,383
| +9% | +$14M |
|
134
Coca-Cola
KO
$294B
| $177M | 0.2% |
3,001,958
+254,936
| +9% | +$15M |
|
|
NOVA
135
DELISTED
Sunnova Energy
NOVA
| $175M | 0.19% |
11,448,117
+1,124,217
| +11% | +$17.1M |
|
136
Entergy
ETR
$39.4B
| $174M | 0.19% |
3,448,108
-1,383,208
| -29% | -$70M |
|
137
Merck
MRK
$210B
| $173M | 0.19% |
1,587,560
-167,489
| -10% | -$18.3M |
|
138
Alnylam Pharmaceuticals
ALNY
$59.4B
| $170M | 0.19% |
885,585
+94,830
| +12% | +$18.2M |
|
139
Dover
DOV
$24.5B
| $169M | 0.19% |
1,100,680
+68,583
| +7% | +$10.5M |
|
140
Global Payments
GPN
$21.2B
| $169M | 0.19% |
1,331,565
+516,955
| +63% | +$65.7M |
|
141
Masco
MAS
$15.5B
| $167M | 0.18% |
2,492,704
+380,429
| +18% | +$25.5M |
|
142
Exxon Mobil
XOM
$479B
| $166M | 0.18% |
1,657,018
-1,517
| -0.1% | -$152K |
|
143
Idexx Laboratories
IDXX
$51.2B
| $165M | 0.18% |
296,665
-65,235
| -18% | -$36.2M |
|
|
BPMC
144
DELISTED
Blueprint Medicines
BPMC
| $162M | 0.18% |
1,753,547
+997,219
| +132% | +$92M |
|
145
Monolithic Power Systems
MPWR
$40.6B
| $161M | 0.18% |
255,348
+22,271
| +10% | +$14M |
|
146
Xcel Energy
XEL
$42.7B
| $160M | 0.18% |
2,587,909
-219,819
| -8% | -$13.6M |
|
147
Neurocrine Biosciences
NBIX
$13.9B
| $160M | 0.18% |
1,213,313
+169,863
| +16% | +$22.4M |
|
148
Ulta Beauty
ULTA
$23.7B
| $160M | 0.18% |
325,788
+80,718
| +33% | +$39.6M |
|
149
Avantor
AVTR
$8.99B
| $157M | 0.17% |
6,864,896
+186,300
| +3% | +$4.25M |
|
150
Equifax
EFX
$29.6B
| $156M | 0.17% |
631,581
-57,185
| -8% | -$14.1M |
|